Six previously published polymerase chain reaction (PCR) assays each targeting different genes were used to speciate 116 isolates previously identified as Campylobacter jejuni using routine microbiological techniques. Of the 116 isolates, 84 were of poultry origin and 32 of human origin. The six PCR assays confirmed the species identities of 31 of 32 (97%) human isolates and 56 of 84 (67%) poultry isolates as C. jejuni. Twenty eight of 84 (33%) poultry isolates were identified as Campylobacter coli and the remaining human isolate was tentatively identified as Campylobacter upsaliensis based on the degree of similarity of 16S rRNA gene sequences. Four of six published PCR assays showed 100% concordance in their ability to speciate 113 of the 116 (97.4%) isolates; two assays failed to generate a PCR product with four to 10 isolates. A C. coli-specific PCR identified all 28 hippuricase gene (hipO)-negative poultry isolates as C. coli although three isolates confirmed to be C. jejuni by the remaining five assays were also positive in this assay. A PCR^restriction fragment length polymorphism assay based on the 16S rRNA gene was developed, which contrary to the results of the six PCR-based assays, identified 28 of 29 hipO-negative isolates as C. jejuni. DNA sequence analysis of 16S rRNA genes from four hipO-negative poultry isolates showed they were almost identical to the C. jejuni type strain 16S rRNA sequences ATCC43431 and ATCC33560 indicating that assays reliant on 16S rRNA sequence may not be suitable for the differentiation of these two species.
Introduction
Campylobacter spp. are recognised as a major cause of human enterocolitis [11, 22] . The two most common species associated with enteritis are C. jejuni and C. coli, of which C. jejuni is responsible for the majority (80^90%) of infections [18] . Campylobacter spp. can be found in the intestinal tract of a wide variety of wild and domesticated animals without obvious clinical signs of disease. The consumption of contaminated food, water and unpasteurised milk and direct contact with infected animals represent con¢rmed routes of transmission to humans. Undercooked poultry represents one of the most common sources of human Campylobacter infection [8] .
Campylobacters are fastidious, poorly hydrolyse a range of sugars and possess few biochemical characteristics that can reliably be used to distinguish between species [2, 3] . Di¡erentiation of C. jejuni from other Campylobacter spp. has relied on its ability to hydrolyse hippurate [22] , although about 10% of C. jejuni isolates do not hydrolyse this metabolite. Genetic diversity within C. jejuni and C. coli has been well established and it has been suggested that this re£ects the ubiquitous nature of these organisms in the environment [22] . Since large outbreaks of Campylobacter enterocolitis are rare and cases are often sporadic, it would be useful to have reliable typing methods to trace sources of infection and routes of transmission. Although several polymerase chain reaction (PCR)-based assays have been developed to facilitate the di¡erentiation of C. jejuni from C. coli [6, 7, 9, 10, 13, 15, 19, 23] , the ability of some of these assays to accurately speciate a collection of Campylobacter isolates of veterinary and human origin has not been evaluated. In this study we examined the ability of six published PCR-based assays to identify 84 Campylobacter isolates cultured from a range of poultry species collected from 13 poultry processing plants across New South Wales, Australia and 32 clinical isolates from human infections from two hospitals in New South Wales, Australia. In addition we developed and evaluated a PCR^RFLP (restriction fragment length polymorphism) assay based on the 16S rRNA gene to speciate this collection.
Materials and methods

Bacterial strains
One hundred and sixteen isolates were used in this study. Eighty four isolates identi¢ed as C. jejuni and sourced from a range of poultry types were supplied by the Elizabeth Macarthur Agricultural Institute, Menangle, Australia. Nineteen human isolates previously identi¢ed as C. jejuni were supplied by the Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Sydney, Australia. Another 13 isolates also previously identi¢ed as C. jejuni were supplied by the John Hunter Hospital (JHH), Newcastle, Australia. The origin of each isolate is listed in Table 1 .
Identi¢cation of C. jejuni isolates
All isolates were cultured on Skirrow's agar (Oxoid, SR69) and sheep blood agar (Oxoid, CM854) in a microaerophilic atmosphere of 5% O 2 , 5% CO 2 and 90% N 2 at 37 ‡C for 48 h. Isolate identi¢cation was based on colony morphology (low, £at, greyish, ¢nely granular and translucent colonies that may spread and swarm or 1^2 mm in diameter, raised, convex, smooth and glistening colonies with an entire edge), typical microscopic appearance in carbol fuchsin-stained smears (small tightly coiled spirals) [2] and positive motility, oxidase, catalase [3] and hippurate hydrolysis tests. Hippurate hydrolysis was determined using hippurate-containing tablets (Rosco Diagnostica, Taastrup, Denmark) used according to the manufacturer's instructions. Streptococcus agalactiae and Erysipelothrix rhusiopathiae were used as positive and negative controls respectively for the hippurate hydrolysis test.
DNA extraction
DNA was extracted by one of two methods. Puri¢ed whole cell DNA was extracted as described previously [4] . Crude whole cell DNA was extracted using InstaGene1 matrix (Bio-Rad, Hercules, CA, USA) according to the manufacturer's instructions. Brie£y, an isolated bacterial colony was resuspended in 1 ml of sterile, pure water (milli Q), centrifuged at 11 000Ug for 1 min and the supernatant was removed. InstaGene1 matrix (200 Wl) was added to the pellet, vortexed brie£y and incubated at 56 ‡C for 30 min. The solution was vortexed for 10 s and heated to 100 ‡C for 8 min, brie£y vortexed and centrifuged at 11 000Ug for 150 s after which 1 Wl was used for PCR.
PCR ampli¢cation
For previously published PCR assays, the sources of the primers and reaction conditions used in this study are listed in Table 2 . Primers CJ16SF and CJ16SR which amplify a 1426-bp fragment of the 16S rRNA gene from di¡erent Campylobacter spp. were designed based upon conserved regions of the 16S rRNA gene sequences from 15 di¡erent species of Campylobacter including C. jejuni strains ATCC33560, CCUG11284, and CCUG24567 (accession numbers M59298, L04315, and L14630 respectively), C. coli strains ATCC3359 and CCUG11283 (acces- [13] , putative oxidoreductase gene [9] , the C. coli-speci¢c putative aspA and £anking sequence [13] and mapA [19] PCRs. RFLP fragments were analysed on 0.7% agarose gels for the 16S rRNA assay and on 2% agarose gels for assays described by Fermer and Engvall, [7] and Jackson et al. [10] . All gels were electrophoresed in 0.5U Tris^borate EDTA bu¡er, visualised with ethidium bromide and recorded electronically using a GelDoc 1000 (Bio-Rad, Richmond, CA, USA).
RFLP analyses
Ampli¢cation products (1426 bp) from the 16S rRNA gene PCR developed for this study were digested separately with RsaI and CfoI (37 ‡C, 16 h). Digestion products were separated on 2.5% agarose, stained with ethidium bromide and visualised as described above. Products ampli¢ed using PCRs developed by Fermer et al., [7] and Jackson et al. [10] were digested (37 ‡C, 16 h) with AluI and DraI respectively.
16S rRNA gene sequencing
16S rRNA gene sequencing was performed as described previously [12] . Sequencing was done using the dRhod- Table 2 Oligonucleotide primers and PCR programmes used in this study
Primer pair This is the size of the product before digestion. 
amine Dye Terminator kit (Applied Biosystems, Foster City, CA, USA) and run on an AB310 automated sequencer (Applied Biosystems). Sequences were edited on both strands using Sequencher1 software (GeneCodes, Ann Arbor, MI, USA) and the resulting proof-read sequences were compared using the BLAST algorithm [1] .
Southern hybridisation
CfoI digested DNA (37 ‡C, 16 h) from a random selection of 14 of 28 hipO PCR-negative Campylobacter isolates (Table 3) were electrophoretically separated using 0.7% agarose and transferred to nylon Hybond H þ membrane (Amersham, Little Chalfont, UK) using standard procedures [17] . DNA was ¢xed to the membrane using UV light and the membrane was probed using a DIG-labelled 735-bp fragment of the hipO gene ampli¢ed using primers described by Linton et al. [13] . Membranes were washed twice under stringent conditions (2U SSC, 0.1% SDS at 68 ‡C, 15 min) as recommended by the manufacturer (Roche Diagnostics, Castle Hill, Australia) prior to exposure to light-sensitive ¢lm.
Nucleotide accession numbers
16S rRNA gene sequences representing Campylobacter isolates 98/C053/1, 98/C053/2, 98/C053/11, 98/C053/12, ICPMR6, ICPMR11, 98/E599/10 and 98/E600/5 have been deposited in the EMBL database with the accession numbers AF372093, AF372094, AF372095, AF372096, AF393205, AF393204, AF393203 and AF393202 respectively.
Results
Identi¢cation of bacterial isolates
One hundred and sixteen isolates comprising 84 from various poultry sources and 32 clinical isolates of human origin were putatively identi¢ed as C. jejuni based on morphological characteristics and biochemical reactions. Repeat tests using the hippurate assay suggested that some isolates unreliably hydrolysed hippurate indicating their species identity was questionable. Linton et al. [13] described a PCR for the ampli¢cation of a portion of the hippuricase (hipO) gene. Using this PCR we con¢rmed that 56 of 84 (67%) poultry isolates and 31 of 32 (97%) human isolates contained the hipO gene ; the remaining 29 isolates failed as template for ampli¢cation of the 735 bp fragment (Tables 3 and 4) . Southern hybridisation analyses of 14 of 28 (50%) hipO-negative poultry isolates using a DIG-labelled 735 bp fragment of the hipO gene con¢rmed that these isolates did not possess hipO ; the remaining hipO negative isolates were not tested (Table 3 ; data not shown). These data indicated that 31 of 32 human isolates and 56 of 84 poultry isolates were C. jejuni. The 29 hipOnegative isolates could be other Campylobacter species or represent hipO-negative C. jejuni [14, 20] and further analyses were required to determine their species identities.
16S rRNA PCR^RFLP and gene sequence analyses
RFLP analysis of the 16S rRNA gene has been used successfully to identify a wide range of bacterial species [21] . Alignment of ¢ve 16S rRNA genes deposited in pub- lic databases for C. jejuni strains ATCC33560, CCUG11284, CCUG24567 (accession numbers M59298, L04315 and L14630 respectively) and C. coli strains ATCC3359 and CCUG11283 (accession numbers M59073 and L04312 respectively) showed that the sequences shared greater than 99.5% sequence similarity within each of these species and 98% similarity between each of these species (data not shown). However, there was su⁄-cient sequence variation to develop an RFLP assay to di¡erentiate between Campylobacter species. An assay was developed with the primary aim of determining the species identities of the 29 hipO-negative isolates. PCR primers (Table 2 ) designed to conserved regions at the 5P-and 3P-end of 16S rRNA genes from a variety of Campylobacter spp. were designed and used to amplify a 1426-bp fragment from 35 isolates including all 29 hipO-negative ; six hipO-positive isolates were included as C. jejunipositive controls. The remaining 87 hipO-positive isolates were not examined in this assay as they were considered to be C. jejuni based on a positive hipO PCR result and other morphological characteristics. Digestion of PCR-ampli¢ed 16S rRNA genes from C. jejuni and C. coli with RsaI and CfoI generated pro¢les capable of di¡erentiating these two species (Fig. 1A) . The six hipO-positive isolates (C. jejuni positive control isolates) generated a RFLP pro¢le with both RsaI (510, 419, 336, 77, 54, 14 bp) and CfoI (363, 353, 264, 220, 184, 63 bp) that was consistent with a C. jejuni 16S rRNA gene sequence although fragments less than 100 bp could not be resolved (Fig. 1A) . Control C. coli strains ATCC3359 and LMG 6440 generated RFLP pro¢les with CfoI (757, 363, 264, 63 bp) and RsaI (510, 419, 405, 77 bp) that were consistent with predicted cleavage sites determined from 16S rRNA gene sequences of C. coli strains ATCC3359 and CCUG11283 (accession numbers M59073 and L04312 respectively (Fig. 1A) . RFLP pro¢les representative of the 28 of 29 hipO-negative Campylobacter isolates surprisingly were consistent with C. jejuni 16S rRNA gene sequences of strains ATCC33560, CCUG11284, CCUG24567; we were unable to amplify a 1426-bp fragment from isolate ICPRM/6. These data suggested that these 28 hipO-negative isolates possessed 16S rRNA gene(s) typical of C. jejuni.
The 16S rRNA gene sequences derived from the four hipO-negative isolates 98/C053/1, 98/C053/2, 98/C053/11, 98/C053/12 (EMBL accession numbers AF372093, AF372094, AF372095, AF372096 respectively) showed 99.7% (three mismatches in 1060 bp) identity to the C. 
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jejuni type strain NCTC 11351T sequence (accession number AF372091). In comparison, the four 16S rRNA gene sequences showed 98.2% (19 mismatches in 1060 bp) sequence identity with the C. coli type strain LMG 6440 sequence (accession number AF372092). Based on 16S rRNA gene sequence analysis the hipO-negative isolates were identi¢ed as C. jejuni con¢rming the ¢ndings of the 16S rRNA PCR^RFLP analysis described above (data not shown). 16S rRNA gene sequence analyses (AF393205) also showed that the hipO-negative human strain (ICPMR/6) possessed a 16S rRNA gene sequence with greatest identity (99.8%, three mismatches in 1341 bp) to C. upsaliensis type strain CCUG14913T (accession number L14628; see later).
Molecular analyses of Campylobacter isolates
Several PCR-based assays have been developed to differentiate between C. jejuni and C. coli [6, 7, 9, 10, 13, 15, 19, 23] . A C. jejuni-speci¢c PCR described by Harmon et al. [9] was reported to amplify a 160-bp fragment of an unidenti¢ed gene. Alignment of primer sequences with the C. jejuni genome sequence [16] enabled us to identify the target gene as a 160-bp fragment of a putative oxidoreductase subunit gene (PID 6967888; Cj0414). Ampli¢ca-tion of a 160-bp portion of the putative oxidoreductase occurred among 31 of 32 human isolates and 56 of 84 poultry isolates (Tables 3 and 4 ) in a pattern that matched exactly the pattern generated using the hipO PCR further con¢rming that these isolates were C. jejuni. None of the hipO PCR negative isolates were template for ampli¢ca-tion of this fragment further adding to the di⁄culty in speciating these isolates and contradicting the results of 16S rRNA gene sequence analyses.
Ampli¢cation of C. coli-speci¢c gene sequences
Linton et al. [13] described the development of a PCR assay that ampli¢es a 500-bp fragment of a C. coli-speci¢c fragment containing the 3P-end of a putative aspartokinase gene and a downstream short open reading frame (ORF) encoding a gene of unknown function. A 500-bp fragment was ampli¢ed in only one of 32 (ICPMR/11) human isolates (Table 4) . A 500-bp fragment was ampli¢ed from 30 poultry isolates (Table 3) . Twenty-eight of these isolates were negative for both the hipO and putative oxidoreductase genes consistent with a C. coli genotype (Table 3) . Two poultry isolates (98/E599/10 and 99/3912/7) were positive for the hipO and putative oxidoreductase genes (Table 3) as was human isolate ICPMR11 (Table 4 ). The species identities of isolates 98/E599/10, 99/3912/7 and ICPMR/11 could not be con¢rmed without further analyses. 16S rRNA gene sequence analysis of isolates 98/E599/ 10 and ICPMR11 showed greatest identity to C. jejuni type strain NCTC11351T (99.8%, three mismatches in 1341 bp).
Ampli¢cation of the C. jejuni-speci¢c mapA gene
Stucki et al. [19] cloned and characterised a C. jejunispeci¢c membrane protein (MAPA) and showed that ampli¢cation of a 641-bp fragment of the mapA gene could reliably di¡erentiate C. jejuni from other Campylobacter species. A 641-bp fragment of mapA was ampli¢ed from 31 of 32 human isolates, a result consistent with the hipO and putative oxidoreductase PCR assays ( Table 4 ). The mapA fragment was ampli¢ed from 52 of 84 poultry isolates (Table 3) . With the exception of a single human isolate (ICPMR/11), all human and poultry isolates positive for the mapA PCR were negative in the C. coli-speci¢c PCR described by Linton et al. [13] (Tables 3 and 4 ). All 52 mapA-positive poultry isolates were also positive for the hipO and putative oxidoreductase genes con¢rming these isolates as C. jejuni (Table 3) . Four isolates (98/E600/ 5, 98/E599/10, 99/3912/7, 99/3912/8), all mapA-negative, were positive for both the hipO and oxidoreductase genes; two of these (98/E599/10, 99/3912/7) were positive in the C. coli-speci¢c PCR. These four isolates were considered to be atypical Campylobacter isolates and required further analyses to con¢rm their species identity. 16S rRNA gene sequences of isolates 98/E600/5 and 98/E599/10 showed 99.9% (one mismatch in 1341) and 99.8% (three mismatches in 1341) identity respectively to C. jejuni type strains ATCC43431 and NCTC11351T.
3.6. Identi¢cation of C. jejuni, C. coli, C. upsaliensis and C. lari based on RFLP analyses of the 23S rRNA gene
Fermer and Engvall [7] described primers capable of amplifying a 491-bp fragment of the 23S rRNA gene of these four Campylobacter spp. RFLP analysis using the restriction endonucleases AluI and Tsp509I was reported to generate speci¢c restriction patterns for each species. RFLP analyses of the 491-bp fragment identi¢ed 27 of 32 human isolates as C. jejuni (Fig. 1B) ; the PCR failed to amplify a product from three isolates (ICPMR/8, ICPMR/9 and JHH1) ( Table 4 ). The results for human isolates ICPMR/6 and ICPMR/11 were inconclusive. RFLP analyses of the poultry isolates identi¢ed 48 of 84 (57%) isolates as C. jejuni; seven isolates failed as a template for ampli¢cation of the 491-bp fragment and one isolate (99/6027/1) showed inconclusive results (Table 3) .
Identi¢cation of C. jejuni, C. coli and C. upsaliensis based on RFLP analyses of a novel gene
Jackson et al. [10] described a PCR assay that ampli¢es a 256-bp fragment of an ORF immediately downstream of a novel two-component regulator gene from the thermophilic Campylobacter spp. C. jejuni, C. coli and C. upsaliensis. Digestion of the 256-bp fragment with restriction endonucleases AluI, DdeI and DraI was su⁄cient to di¡er-entiate between these three Campylobacter species [10] . RFLP analyses of the 256 bp fragment identi¢ed 31 of 32 human Campylobacter isolates as C. jejuni (Fig. 1C) . Isolate ICPMR6 (negative for the hipO, oxidoreductase, mapA PCRs and the C. coli-speci¢c PCR) could not be accurately characterised using this assay. 16S rRNA gene sequence analysis of isolate ICPMR/6 showed greatest identity to C. upsaliensis type strain CCUG14913T. RFLP analyses of the 84 poultry isolates showed that 56 were C. jejuni. Of these, 52 (93%) were PCR-positive for the hipO, mapA and oxidoreductase genes and negative in the C. coli-speci¢c PCR. The remaining four isolates (98/ E600/5, 98/E599/10, 99/3912/7, 99/3912/8) appeared to be mapA-negative C. jejuni; two of these (98/E599/10, 99/ 3912/7) were positive for the C. coli-speci¢c gene fragment.
Discussion
Several PCR-based assays have been developed to determine the species identity of Campylobacter spp. although we were unable to ¢nd any reports comparing the accuracy of these assays on a geographically diverse collection of Campylobacter isolates of poultry and human origin. We used a panel of six published PCR assays to speciate a collection of 116 Campylobacter isolates which had been previously identi¢ed as C. jejuni based on their ability to hydrolyse hippurate. We con¢rmed that 87 of 116 isolates were C. jejuni; 28 of the remaining 29 isolates were shown to be C. coli. One isolate (ICPMR/6) could not be identi¢ed using any of the published assays but had a 16S rRNA gene sequence with highest sequence identity to the C. upsaliensis type strain. However, the PCR-RFLP assays of Fermer and Engvall [7] and Jackson et al. [10] could not con¢rm this tentative species identi¢cation. PCR assays that ampli¢ed a putative oxidoreductase [9] and hipO [13] and a PCR^RFLP assay developed by Jackson et al. [10] each con¢rmed that 56 of 84 poultry and 31 of 32 human isolates were C. jejuni (100% concordance). The assay of Stucki et al. [19] identi¢ed 52 of 84 poultry and 31 of 32 human isolates as C. jejuni: four poultry isolates (98/ E600/5, 98/E599/10, 99/3912/7 and 8) con¢rmed to be C. jejuni based on the collective results of a minimum of three other molecular assays were negative in this assay. The inability to amplify a PCR product with these four isolates may re£ect minor sequence variations in either one or both primer sites or the presence of PCR inhibitors in the whole cell DNA preparations. The PCR^RFLP assays described by Fermer and Engvall [7] was the most unreliable assay as it did not generate a PCR amplicon for 10 isolates and a further three isolates generated RFLP patterns that could not be typed. The C. coli-speci¢c PCR [13] accurately identi¢ed all 28 C. coli isolates. However, three C. jejuni isolates (two poultry and one human) were positive with this assay suggesting that the C. coli-speci¢c PCR of Linton et al., [13] should not be the sole assay used to con¢rm a C. coli species designation.
Although C. jejuni is the only Campylobacter species that hydrolyses hippurate Totten et al. [20] described hippurate-negative C. jejuni isolates and recommended that hippurate hydrolysis should not be used as the sole criterion for di¡erentiating thermophilic Campylobacter spp. In this study, we observed that results of hippurate hydrolysis were not always reproducible and that weakly positive reactions were open to interpretation and varied in intensity depending upon inoculant size. A recent study by Engvall et al. (2002) [5] reported that 52 of 174 Campylobacter isolates recovered from di¡erent domestic and wild animals and which had initially been identi¢ed as either C. jejuni, C. coli, C. lari or C. upsaliensis were either incorrect or unreliable. Our data and those of Engvall et al. [5] suggest that phenotypic and biochemical assays are unreliable for speciating Campylobacters, particularly those recovered from non-human sources.
Campylobacter spp. are common inhabitants of a range of domesticated meat-producing animals and are a common cause of gastrointestinal disease in humans. We demonstrated that the hippurate hydrolysis test was particu-larly unreliable since 29 hipO-negative isolates, particularly those of poultry origin were positive in this biochemical test. Furthermore, the 16S rRNA RFLP assay developed in this study could not con¢rm a C. coli species designation for any of the 28 hipO-negative poultry isolates. RFLP pro¢les consistently showed patterns consistent with a C. jejuni 16S rRNA gene sequence. This was con¢rmed when DNA sequence analysis of 16S rRNA genes from four isolates (98/C053/1, 2, 11, 12) identi¢ed to be C. coli using six di¡erent PCR-based assays showed sequences with highest identity to 16S rRNA genes of the C. jejuni type strain. These data suggest that there is insu⁄-cient sequence variation in the 16S rRNA gene to discriminate among this group of closely related bacteria.
